Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Comparing two types of gastric bypass for treating type 2 diabetes

Official title: Efficacy and Safety of One-anastomosis Versus Roux-en-Y Gastric Bypass for Type 2 Diabetes Remission (ORDER): a Multi-centric, Randomized, Open-label, Superiority Trial

Run by Beijing Friendship Hospital · NCT05015283 · Data updated 2026-11-12

This study is testing which type of gastric bypass surgery, one-anastomosis or Roux-en-Y, works better for helping people with obesity and type 2 diabetes lose weight and improve their diabetes.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment248 (estimated)
SponsorBeijing Friendship Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedFebruary 1, 2022
Main results expectedOctober 1, 2026
Study endsDecember 31, 2026
Registry record updatedAugust 3, 2022
Trial IDNCT05015283 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are East Asian adults aged 21-65 with obesity and type 2 diabetes who meet specific BMI and diabetes duration criteria.

Probably not a fit

Patients with a history of gastrointestinal surgery, serious cardiovascular diseases, or other significant health issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare the efficacy and safety of one-anastomosis gastric bypass (OAGB) versus Roux-en-Y gastric bypass (RYGB) in patients with type 2 diabetes mellitus (T2DM) who are also dealing with obesity. The study will involve participants aged 21-65 with a BMI between 27.5 and 50 kg/m2, who have been diagnosed with T2DM for at least six months and are currently on diabetes medications. The primary focus will be on weight loss and the effectiveness of these two surgical methods in achieving diabetes remission. The trial is being conducted at Beijing Friendship Hospital and involves collaboration with several other hospitals in China.

Why it matters

Potential benefit: If successful, this study could provide insights into more effective surgical options for achieving diabetes remission in obese patients.

How similar studies have gone: Previous studies have shown promising results for both surgical methods, but this direct comparison is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 21-65 years old, Male/Female, East Asian population
* 50 kg/m2≥BMI≥27.5kg/m2
* Type 2 diabetes duration ≥6 months
* HbA1c≥7.0%
* Currently receiving one or more oral/injectable hypoglycemic drugs (insulin /glucagon-like peptide-1 receptor agonist)
* Recommendation for OAGB/RYGB evaluated by a multidisciplinary team

Exclusion Criteria:

* Underwent gastrointestinal surgery (gastric/duodenal surgery or bariatric surgery)
* Fasting C-peptide level lower than 1/2 normal minimum
* Active gastrointestinal ulcer is present
* Helicobacter pylori infection is present
* A history of serious cardiovascular and cerebrovascular diseases (myocardial infarction, stroke, etc.)
* A history of cirrhosis (Child-Pugh≥A)
* A history of chronic kidney disease (eGFR )\< 60 ml/min / 1.73 m2)
* Inflammatory bowel disease is present (ulcerative colitis, Crohn's disease)
* Chronic anemia is present, Hgb for male \<100g/L, for female \<90g/L
* A desire to conception during the study period
* Uncontrolled mental and psychological disorders are present
* Expected survival\<5 years of end-stage disease or previous/current malignant tumor
* Participated in clinical studies/trials that have the conflict of interest with the study
* Unable to understand, refuse to participate and sign the informed consent
* Gallstones require cholecystectomy
* Reflux esophagitis above grade A

Where it's running

  • Beijing Friendship Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Zhongtao Zhang, M.D.;Ph.D — Beijing Friendship Hospital
  • Study coordinator: Zhongtao Zhang, M.D.;Ph.D
  • Email: zhangzht@ccmu.edu.cn
  • Phone: +86-13801060364

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.